EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Furosemide rescues hypercalciuria in familial hypomagnesaemia with hypercalciuria and nephrocalcinosis model

Natalia Kriuchkova iD, Tilman Breiderhoff, Dominik Müller, Duygu Elif Yilmaz, Hasan Demirci, Hoora Drewell, Dorothee Günzel, Nina Himmerkus, Markus Bleich iD, Pontus B Persson, Kerim Mutig iD

Acta Physiologica · 2023-03 · 237 (3)

DOI: 10.1111/apha.13927 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Physiologica, online erschienen am 24.01.2023. Verfasst von Natalia Kriuchkova und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Translational Physiology, Charité-Universitätsmedizin Berlin, Berlin, Germany. Hauptthemen laut MEDLINE: Furosemide, Nephrocalcinosis, Hypercalciuria. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Forschungsgemeinschaft.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

Perturbed calcium homeostasis limits life expectancy in familial hypomagnesaemia with hypercalciuria and nephrocalcinosis (FHHNC). This rare disease occurs by loss‐of‐function mutations in CLDN16 or CLDN19 genes, causing impaired paracellular reabsorption of divalent cations along the cortical thick ascending limb (cTAL). Only partial compensation takes place in the ensuing late distal convoluted tubule, connecting tubule, and collecting duct, where the luminal transient receptor potential channel V5 (TRPV5), as well as basolateral plasma membrane calcium ATPase (PMCA) and sodium‐potassium exchanger (NCX1) mediate transcellular Ca 2+ reabsorption. The loop diuretic furosemide induces compensatory activation in these distal segments. Normally, furosemide enhances urinary calcium excretion via inhibition of the aforementioned cTAL. As Ca 2+ reabsorption in the cTAL is already severely impaired in FHHNC patients, furosemide may alleviate hypercalciuria in this disease by activation of the distal transcellular Ca 2+ transport proteins.

Methods

Cldn16‐deficient mice (Cldn16 −/− ) served as a FHHNC model. Wild‐type (WT) and Cldn16 −/− mice were treated with furosemide (7 days of 40 mg/kg bw) or vehicle. We assessed renal electrolyte handling (metabolic cages) and key divalent transport proteins.

Results

Cldn16 −/− mice show higher Ca 2+ excretion than WT and compensatory stimulation of Cldn2, TRPV5, and NCX1 at baseline. Furosemide reduced hypercalciuria in Cldn16 −/− mice and enhanced TRPV5 and PMCA levels in Cldn16 −/− but not in WT mice.

Conclusions

Furosemide significantly reduces hypercalciuria, likely via upregulation of luminal and basolateral Ca 2+ transport systems in the distal nephron and collecting duct in this model for FHHNC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FurosemideNephrocalcinosisHypercalciuriaCarrier ProteinsMagnesiumRenal Tubular Transport, Inborn ErrorsCalciumMiceAnimalsClaudins

Stichwörter der Autor:innen

TRPV5claudin-16distal calcium reabsorption

Substanzen

CalciumCarrier ProteinsClaudinsFurosemideMagnesium

Autor:innen und Institutionen

  • Department of Translational Physiology, Charité-Universitätsmedizin Berlin, Berlin, Germany.
  • Division of Gastroenterology, Nephrology and Metabolic Diseases, Department of Pediatrics, Charité-Universitätsmedizin Berlin, Berlin, Germany.
  • Department of Functional Anatomy, Charité-Universitätsmedizin Berlin, Berlin, Germany.
  • Clinical Physiology/Division of Nutritional Medicine, Charité-Universitätsmedizin Berlin, Berlin, Germany.
  • Institute of Physiology, Kiel University, Kiel, Germany.

ORCID-Profile: Natalia Kriuchkova, Markus Bleich, Kerim Mutig

Förderung

  • Deutsche Forschungsgemeinschaft

Zitieren

APA

Kriuchkova, N., Breiderhoff, T., Müller, D., Yilmaz, D. E., Demirci, H., Drewell, H., Günzel, D., Himmerkus, N., Bleich, M., Persson, P. B., & Mutig, K. (2023). Furosemide rescues hypercalciuria in familial hypomagnesaemia with hypercalciuria and nephrocalcinosis model. Acta Physiologica, 237(3). https://doi.org/10.1111/apha.13927

Vancouver

Kriuchkova N, Breiderhoff T, Müller D, Yilmaz DE, Demirci H, Drewell H, et al. Furosemide rescues hypercalciuria in familial hypomagnesaemia with hypercalciuria and nephrocalcinosis model. Acta Physiologica. 2023;237(3). doi:10.1111/apha.13927

BibTeX
@article{Kriuchkova2023,
  author = {Kriuchkova, Natalia and Breiderhoff, Tilman and Müller, Dominik and Yilmaz, Duygu Elif and Demirci, Hasan and Drewell, Hoora and Günzel, Dorothee and Himmerkus, Nina and Bleich, Markus and Persson, Pontus B and Mutig, Kerim},
  title = {Furosemide rescues hypercalciuria in familial hypomagnesaemia with hypercalciuria and nephrocalcinosis model},
  journal = {Acta Physiologica},
  year = {2023},
  volume = {237},
  number = {3},
  doi = {10.1111/apha.13927}
}
Kostenlos starten →